^
BIOMARKER:

HER-2 overexpression

i
Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
HER-2 overexpression
Ovarian Cancer
fam-trastuzumab deruxtecan-nxki
Sensitive
:
D
IGCS 2022 - 2 weeks - (New D)
HER-2 overexpression
Non Small Cell Lung Cancer
fam-trastuzumab deruxtecan-nxki
Sensitive
:
C2
ESMO 2022 - 3 weeks - (New C3)
HER-2 overexpression
Gastric Cancer
trastuzumab
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
trastuzumab-qyyp
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
trastuzumab-qyyp
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
trastuzumab-qyyp
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
trastuzumab-dttb
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
trastuzumab-dttb
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
trastuzumab-dttb
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
trastuzumab-dkst
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
trastuzumab-dkst
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
trastuzumab-dkst
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
trastuzumab-anns
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
trastuzumab-anns
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
trastuzumab-anns
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
trastuzumab-pkrb
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
trastuzumab-pkrb
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
trastuzumab-pkrb
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
lapatinib
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Negative Breast Cancer
trastuzumab + lapatinib
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
lapatinib
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
trastuzumab
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
trastuzumab / hyaluronidase-oysk
Sensitive
:
A1
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
neratinib
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
trastuzumab-dttb
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
trastuzumab-qyyp
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
trastuzumab-pkrb
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
trastuzumab-anns
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
trastuzumab-dkst
Sensitive
:
A1
HER-2 overexpression
HER2 Positive Breast Cancer
trastuzumab
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Gastroesophageal Junction Adenocarcinoma
trastuzumab
Sensitive
:
A1
HER-2 overexpression
Gastric Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 overexpression
Breast Cancer
trastuzumab + docetaxel
Sensitive
:
A1